LNC Bio will carry out a paid-in capital increase of approximately 140.6 billion won, followed by a 1-for-1 free capital increase. The Korea Exchange suspended trading of the stock citing the free capital increase as the reason.

140.6 Billion Won Paid-In Capital Increase... Securing Funds for Facility Investment

LNC Bio announced through a regulatory filing on the 31st that it has decided on a paid-in capital increase via a shareholder allotment followed by a public offering of unsubscribed shares, issuing 3.7 million common shares. The issue price per share is 38,000 won, bringing the total amount to be raised to approximately 140.6 billion won.

• The raised funds will be allocated as follows:
• Facility investment funds: 105 billion won
• Operating funds: 20.6 billion won
• Debt repayment funds: 15 billion won

The record date for the new share allotment is September 4, 2026, with 0.1356149558 new shares allocated per existing share. The employee stock ownership association will be preferentially allotted 74,000 shares, representing 2% of the total shares to be issued.

Subscription for existing shareholders will take place from October 14 to 15, and if unsubscribed shares remain, a public offering will be conducted from October 19 to 20. The payment date is October 22, and the new shares are scheduled to be listed on November 3.

1-for-1 Free Capital Increase After Completion of Paid-In Capital Increase

The company will also conduct a 1-for-1 free capital increase following the completion of the paid-in capital increase. The record date for the free capital increase allotment is October 27, 2026, and one new common share will be allotted free of charge for each existing share held to shareholders registered on the shareholder registry after the paid-in capital increase. New shares acquired through the paid-in capital increase will also be included in the free capital increase.

A total of 30,437,464 new shares will be issued under the free capital increase, with a scheduled listing date of November 11. Following the free capital increase, the total number of issued shares, including treasury shares, will increase to 61,107,168.

Exchange Suspends Trading

The Korea Exchange announced that it has suspended trading of LNC Bio common shares starting from 3:56 p.m. on July 31, 2026, until market close, citing the free capital increase as the reason. The Exchange noted that off-hours trading will not be executed before market hours on the day trading resumes.